Heat Biologics, Inc. Reports 2014 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Heat Biologics (HTBX) Posts Q2 Loss of 44c/Share
August 14, 2014 7:15 AM EDTHeat Biologics (NASDAQ: HTBX) reported Q2 EPS of ($0.44), $0.04 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Heat Biologics (HTBX) click here.
... More